Start recovery right
It's time to raise the bar for post-op recovery
of orthopaedic patients can suffer from post-operative blisters caused by dressings
extra spent in hospital as a result of SSIs in post-op patients
additional costs for patients who acquire an SSI
Every patient is unique, and their surgery is no different. At Mölnlycke we recognise that risk assessment is a fundamental part of establishing the needs of a patients care pathway; pre, intra and post-op. When risk changes, the care should too.
Whether it’s an advanced wound dressing or negative pressure wound therapy, our risk assessment framework helps you to inform the care that patients need, based on their individual risk factors.
- Supporting informed decision making for HCP’s
- Encouraging patient contribution and responsibility to their own risk reduction
Learn more about the ASA physical status classification system on asahq.org , American Society of Anesthesiologists
Learn more about the Wound Classification on CDC, Centers for Disease Control and Prevention
For full list of references relating to the Risk Assesment framework please click here
Our goal is to give patients the best chance of recovery, without complication and with that, we keep the development of our wound recovery solutions at the heart of everything we do. Our clinical standard Avance® Solo negative pressure device for closed surgical incisions and our best in class Mepilex® Border Post-Op dressing with Safetac® technology, together with our risk assessment framework, enables targeted treatment choices to be made based on patient need, rather than taking a generic approach to recovery.
Our goal is to redefine what good post-op recovery looks like. We’re committed to constantly improving out offer and ultimately better aid recovery and lower the risk for patients. You and your team play a key role in helping to ensure recovery starts right too, listen to our podcast with Rhidian Morgan Jones and hear about the impacts of using cheap dressings with high-risk orthopedic surgery.